| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | dolichyl pyrophosphate Glc2Man9GlcNAc2 alpha-1,2-glucosyltransferase activity | 2.29e-05 | 2 | 96 | 2 | GO:0106073 | |
| GeneOntologyBiologicalProcess | locomotory behavior | 5.05e-05 | 284 | 95 | 8 | GO:0007626 | |
| GeneOntologyBiologicalProcess | cilium movement involved in cell motility | 5.31e-05 | 210 | 95 | 7 | GO:0060294 | |
| GeneOntologyBiologicalProcess | cilium-dependent cell motility | 6.16e-05 | 215 | 95 | 7 | GO:0060285 | |
| GeneOntologyBiologicalProcess | cilium or flagellum-dependent cell motility | 6.16e-05 | 215 | 95 | 7 | GO:0001539 | |
| GeneOntologyCellularComponent | cell surface | SIGLEC12 SELP CACNA1C DPP4 IL13RA1 VPREB1 CRLF1 NRCAM PSG7 LYZL6 LY6G5B HHLA2 ABCG1 PTPRC CNTNAP2 LRP2 TACR1 IL4R IL6ST | 5.93e-07 | 1111 | 96 | 19 | GO:0009986 |
| GeneOntologyCellularComponent | external side of plasma membrane | SIGLEC12 SELP IL13RA1 VPREB1 CRLF1 NRCAM LY6G5B HHLA2 ABCG1 PTPRC LRP2 IL4R IL6ST | 7.23e-07 | 519 | 96 | 13 | GO:0009897 |
| GeneOntologyCellularComponent | side of membrane | SIGLEC12 SELP IL13RA1 VPREB1 CRLF1 NRCAM SPTA1 ALG10B LY6G5B HHLA2 ABCG1 PTPRC FRMD6 LRP2 IL4R IL6ST | 2.22e-06 | 875 | 96 | 16 | GO:0098552 |
| GeneOntologyCellularComponent | 9+2 motile cilium | 1.14e-04 | 238 | 96 | 7 | GO:0097729 | |
| GeneOntologyCellularComponent | CLOCK-BMAL transcription complex | 2.07e-04 | 5 | 96 | 2 | GO:1990513 | |
| GeneOntologyCellularComponent | sperm midpiece | 2.15e-04 | 64 | 96 | 4 | GO:0097225 | |
| GeneOntologyCellularComponent | axon initial segment | 3.14e-04 | 29 | 96 | 3 | GO:0043194 | |
| GeneOntologyCellularComponent | sperm flagellum | 4.63e-04 | 214 | 96 | 6 | GO:0036126 | |
| GeneOntologyCellularComponent | motile cilium | 1.26e-03 | 355 | 96 | 7 | GO:0031514 | |
| MousePheno | abnormal nervous system electrophysiology | NRCAM KALRN CHD8 GRM1 THOC2 CLOCK SCN1A CNTNAP2 TACR1 NOS2 IL6ST NPAS2 | 5.85e-07 | 329 | 84 | 12 | MP:0002272 |
| MousePheno | increased locomotor activity | 1.13e-05 | 178 | 84 | 8 | MP:0031391 | |
| MousePheno | increased IgG level | 2.72e-05 | 201 | 84 | 8 | MP:0002493 | |
| MousePheno | increased IgA level | 4.66e-05 | 66 | 84 | 5 | MP:0002495 | |
| MousePheno | increased granulocyte number | SELP DPP4 IL13RA1 SPTA1 CLOCK ADGB ABCG1 PTPRC PIK3C2A TBX20 IL4R IL6ST NPAS2 | 5.30e-05 | 597 | 84 | 13 | MP:0000322 |
| MousePheno | abnormal forebrain morphology | COL4A2 CACNA1C KALRN SPTA1 CASP6 THOC2 CLOCK ALG10B SCN1A ALG10 STON2 CNTNAP2 LRP2 DHX35 RERE TBX20 NOS2 IL6ST | 5.39e-05 | 1072 | 84 | 18 | MP:0000783 |
| MousePheno | abnormal macrophage physiology | SIGLEC12 SELP DOCK11 DOCK10 ANO5 ABCG1 PTPRC NOS2 MMD IL4R IL6ST | 7.76e-05 | 451 | 84 | 11 | MP:0002451 |
| MousePheno | abnormal granulocyte number | SELP DPP4 IL13RA1 SPTA1 CLOCK ADGB ABCG1 SAMD9L PTPRC PIK3C2A TBX20 NOS2 IL4R IL6ST NPAS2 | 7.93e-05 | 805 | 84 | 15 | MP:0020201 |
| MousePheno | abnormal myelopoiesis | 7.93e-05 | 119 | 84 | 6 | MP:0001601 | |
| MousePheno | increased single-positive T cell number | 9.40e-05 | 40 | 84 | 4 | MP:0008082 | |
| MousePheno | increased CD4-positive, alpha-beta T cell number | 9.80e-05 | 241 | 84 | 8 | MP:0008074 | |
| MousePheno | impaired macrophage chemotaxis | 1.04e-04 | 41 | 84 | 4 | MP:0003799 | |
| MousePheno | abnormal susceptibility to parasitic infection | 1.04e-04 | 125 | 84 | 6 | MP:0020184 | |
| MousePheno | abnormal granulocyte morphology | SELP DPP4 IL13RA1 SPTA1 CLOCK ADGB ABCG1 SAMD9L PTPRC PIK3C2A TBX20 NOS2 IL4R IL6ST NPAS2 | 1.19e-04 | 835 | 84 | 15 | MP:0002441 |
| MousePheno | abnormal optic vesicle formation | 1.78e-04 | 47 | 84 | 4 | MP:0003425 | |
| MousePheno | abnormal bone marrow cell morphology/development | SELP IL13RA1 SPTA1 CLOCK ADGB ABCG1 SAMD9L PTPRC PIK3C2A NOS2 MMD IL4R IL6ST | 2.82e-04 | 706 | 84 | 13 | MP:0002398 |
| MousePheno | abnormal body wall morphology | 2.92e-04 | 151 | 84 | 6 | MP:0003385 | |
| MousePheno | abnormal telencephalon morphology | CACNA1C KALRN SPTA1 CASP6 THOC2 CLOCK SCN1A STON2 CNTNAP2 LRP2 DHX35 RERE NOS2 IL6ST | 3.16e-04 | 812 | 84 | 14 | MP:0000787 |
| MousePheno | abnormal somite shape | 3.28e-04 | 55 | 84 | 4 | MP:0001691 | |
| MousePheno | abnormal fetal cardiomyocyte physiology | 3.28e-04 | 55 | 84 | 4 | MP:0011390 | |
| MousePheno | abnormal macrophage chemotaxis | 3.51e-04 | 56 | 84 | 4 | MP:0010760 | |
| MousePheno | abnormal follicular B cell physiology | 3.53e-04 | 5 | 84 | 2 | MP:0008191 | |
| MousePheno | increased neutrophil cell number | 3.56e-04 | 368 | 84 | 9 | MP:0000219 | |
| MousePheno | abnormal forebrain development | 4.04e-04 | 225 | 84 | 7 | MP:0003232 | |
| MousePheno | abnormal inguinal lymph node morphology | 4.38e-04 | 25 | 84 | 3 | MP:0002353 | |
| MousePheno | increased immunoglobulin level | 4.85e-04 | 305 | 84 | 8 | MP:0002461 | |
| MousePheno | increased T cell number | DPP4 IL13RA1 SPTA1 DOCK10 CLOCK ABCG1 PTPRC PIK3C2A NOS2 IL6ST | 5.42e-04 | 475 | 84 | 10 | MP:0005015 |
| MousePheno | abnormal vocalization | 5.51e-04 | 237 | 84 | 7 | MP:0001529 | |
| MousePheno | increased alpha-beta T cell number | 5.52e-04 | 311 | 84 | 8 | MP:0012764 | |
| MousePheno | abnormal CD4-positive, alpha-beta T cell number | 5.52e-04 | 391 | 84 | 9 | MP:0008073 | |
| MousePheno | abnormal myeloid leukocyte morphology | SELP DPP4 IL13RA1 DOCK11 SPTA1 ANO5 CLOCK ADGB ABCG1 SAMD9L PTPRC PIK3C2A TBX20 NOS2 MMD IL4R IL6ST NPAS2 | 5.57e-04 | 1292 | 84 | 18 | MP:0008250 |
| MousePheno | abnormal brain wave pattern | 5.86e-04 | 64 | 84 | 4 | MP:0004994 | |
| MousePheno | abnormal eye development | 6.07e-04 | 482 | 84 | 10 | MP:0001286 | |
| MousePheno | abnormal ear development | 6.22e-04 | 65 | 84 | 4 | MP:0003938 | |
| MousePheno | abnormal susceptibility to infection | SIGLEC12 SELP DPP4 IL13RA1 SPTA1 RNF123 SAMD9L PTPRC OASL NOS2 IL4R IL6ST | 6.50e-04 | 672 | 84 | 12 | MP:0001793 |
| MousePheno | increased eosinophil cell number | 7.00e-04 | 178 | 84 | 6 | MP:0005011 | |
| Domain | DUF3398 | 2.60e-06 | 6 | 96 | 3 | PF11878 | |
| Domain | DOCK_C/D_N | 2.60e-06 | 6 | 96 | 3 | IPR021816 | |
| Domain | FN3 | 8.58e-06 | 199 | 96 | 8 | PS50853 | |
| Domain | FN3_dom | 1.23e-05 | 209 | 96 | 8 | IPR003961 | |
| Domain | DHR-1_domain | 2.11e-05 | 11 | 96 | 3 | IPR027007 | |
| Domain | DHR_2 | 2.11e-05 | 11 | 96 | 3 | PS51651 | |
| Domain | DHR_1 | 2.11e-05 | 11 | 96 | 3 | PS51650 | |
| Domain | DHR-2 | 2.11e-05 | 11 | 96 | 3 | PF06920 | |
| Domain | DOCK | 2.11e-05 | 11 | 96 | 3 | IPR026791 | |
| Domain | DOCK_C | 2.11e-05 | 11 | 96 | 3 | IPR010703 | |
| Domain | DOCK-C2 | 2.11e-05 | 11 | 96 | 3 | PF14429 | |
| Domain | DHR-2 | 2.11e-05 | 11 | 96 | 3 | IPR027357 | |
| Domain | Alg10 | 2.61e-05 | 2 | 96 | 2 | IPR016900 | |
| Domain | DIE2_ALG10 | 2.61e-05 | 2 | 96 | 2 | PF04922 | |
| Domain | FN3 | 4.74e-05 | 185 | 96 | 7 | SM00060 | |
| Domain | - | SIGLEC12 IL13RA1 VPREB1 SDK2 CRLF1 NRCAM KALRN PSG7 HHLA2 PTPRC IL4R IL6ST | 1.48e-04 | 663 | 96 | 12 | 2.60.40.10 |
| Domain | FGF | 1.89e-04 | 22 | 96 | 3 | PF00167 | |
| Domain | HBGF_FGF | 1.89e-04 | 22 | 96 | 3 | PS00247 | |
| Domain | FGF | 1.89e-04 | 22 | 96 | 3 | SM00442 | |
| Domain | Fibroblast_GF_fam | 1.89e-04 | 22 | 96 | 3 | IPR002209 | |
| Domain | fn3 | 1.89e-04 | 162 | 96 | 6 | PF00041 | |
| Domain | IL-1_fam/FGF_fam | 2.16e-04 | 23 | 96 | 3 | IPR028142 | |
| Domain | Ig-like_fold | SIGLEC12 IL13RA1 VPREB1 SDK2 CRLF1 NRCAM KALRN PSG7 HHLA2 PTPRC IL4R IL6ST | 2.65e-04 | 706 | 96 | 12 | IPR013783 |
| Domain | Nuc_translocat | 7.17e-04 | 8 | 96 | 2 | IPR001067 | |
| Domain | Cytokine_IL1-like | 8.31e-04 | 36 | 96 | 3 | IPR008996 | |
| Domain | IL6Ra-bind | 1.40e-03 | 11 | 96 | 2 | PF09240 | |
| Domain | HlyIII | 1.40e-03 | 11 | 96 | 2 | PF03006 | |
| Domain | AdipoR/HlyIII-related | 1.40e-03 | 11 | 96 | 2 | IPR004254 | |
| Domain | TypeI_recpt_CBD | 1.40e-03 | 11 | 96 | 2 | IPR015321 | |
| Domain | FERM_M | 1.70e-03 | 46 | 96 | 3 | PF00373 | |
| Domain | - | 2.04e-03 | 49 | 96 | 3 | 1.20.80.10 | |
| Domain | FERM_central | 2.04e-03 | 49 | 96 | 3 | IPR019748 | |
| Domain | FERM_domain | 2.04e-03 | 49 | 96 | 3 | IPR000299 | |
| Domain | FERM/acyl-CoA-bd_prot_3-hlx | 2.17e-03 | 50 | 96 | 3 | IPR014352 | |
| Domain | FERM_1 | 2.17e-03 | 50 | 96 | 3 | PS00660 | |
| Domain | FERM_2 | 2.17e-03 | 50 | 96 | 3 | PS00661 | |
| Domain | FERM_3 | 2.17e-03 | 50 | 96 | 3 | PS50057 | |
| Domain | Band_41_domain | 2.17e-03 | 50 | 96 | 3 | IPR019749 | |
| Domain | B41 | 2.17e-03 | 50 | 96 | 3 | SM00295 | |
| Domain | ATPase_dyneun-rel_AAA | 2.29e-03 | 14 | 96 | 2 | IPR011704 | |
| Domain | AAA_5 | 2.29e-03 | 14 | 96 | 2 | PF07728 | |
| Domain | Ubiquitin-rel_dom | 2.61e-03 | 184 | 96 | 5 | IPR029071 | |
| Domain | IG_LIKE | 3.79e-03 | 491 | 96 | 8 | PS50835 | |
| Domain | - | 4.04e-03 | 391 | 96 | 7 | 2.30.29.30 | |
| Domain | Ig-like_dom | 4.38e-03 | 503 | 96 | 8 | IPR007110 | |
| Pathway | REACTOME_FGFR2C_LIGAND_BINDING_AND_ACTIVATION | 2.50e-05 | 12 | 70 | 3 | MM14728 | |
| Pathway | REACTOME_FGFR2C_LIGAND_BINDING_AND_ACTIVATION | 3.24e-05 | 13 | 70 | 3 | M1087 | |
| Pathway | REACTOME_FGFR3_LIGAND_BINDING_AND_ACTIVATION | 3.24e-05 | 13 | 70 | 3 | M27061 | |
| Pathway | REACTOME_FGFR3_LIGAND_BINDING_AND_ACTIVATION | 3.24e-05 | 13 | 70 | 3 | MM14723 | |
| Pathway | REACTOME_PHOSPHOLIPASE_C_MEDIATED_CASCADE_FGFR4 | 5.11e-05 | 15 | 70 | 3 | M27509 | |
| Pathway | REACTOME_PHOSPHOLIPASE_C_MEDIATED_CASCADE_FGFR4 | 5.11e-05 | 15 | 70 | 3 | MM15235 | |
| Pathway | REACTOME_PHOSPHOLIPASE_C_MEDIATED_CASCADE_FGFR2 | 7.59e-05 | 17 | 70 | 3 | MM15234 | |
| Pathway | REACTOME_SHC_MEDIATED_CASCADE_FGFR3 | 7.59e-05 | 17 | 70 | 3 | MM15244 | |
| Pathway | REACTOME_PHOSPHOLIPASE_C_MEDIATED_CASCADE_FGFR2 | 9.07e-05 | 18 | 70 | 3 | M27508 | |
| Pathway | REACTOME_SHC_MEDIATED_CASCADE_FGFR3 | 9.07e-05 | 18 | 70 | 3 | M27518 | |
| Pathway | REACTOME_PI_3K_CASCADE_FGFR3 | 9.07e-05 | 18 | 70 | 3 | M27521 | |
| Pathway | REACTOME_PI_3K_CASCADE_FGFR3 | 9.07e-05 | 18 | 70 | 3 | MM15247 | |
| Pathway | REACTOME_FGFR2_LIGAND_BINDING_AND_ACTIVATION | 9.07e-05 | 18 | 70 | 3 | MM14724 | |
| Pathway | REACTOME_SHC_MEDIATED_CASCADE_FGFR4 | 1.07e-04 | 19 | 70 | 3 | MM15250 | |
| Pathway | REACTOME_FRS_MEDIATED_FGFR3_SIGNALING | 1.07e-04 | 19 | 70 | 3 | MM15245 | |
| Pathway | REACTOME_FRS_MEDIATED_FGFR3_SIGNALING | 1.26e-04 | 20 | 70 | 3 | M27519 | |
| Pathway | REACTOME_PI_3K_CASCADE_FGFR4 | 1.26e-04 | 20 | 70 | 3 | M27525 | |
| Pathway | REACTOME_SHC_MEDIATED_CASCADE_FGFR4 | 1.26e-04 | 20 | 70 | 3 | M27524 | |
| Pathway | REACTOME_PI_3K_CASCADE_FGFR4 | 1.26e-04 | 20 | 70 | 3 | MM15251 | |
| Pathway | REACTOME_FGFR2_LIGAND_BINDING_AND_ACTIVATION | 1.26e-04 | 20 | 70 | 3 | M27062 | |
| Pathway | REACTOME_FRS_MEDIATED_FGFR4_SIGNALING | 1.46e-04 | 21 | 70 | 3 | MM15248 | |
| Pathway | REACTOME_SHC_MEDIATED_CASCADE_FGFR2 | 1.46e-04 | 21 | 70 | 3 | MM15242 | |
| Pathway | REACTOME_FRS_MEDIATED_FGFR4_SIGNALING | 1.69e-04 | 22 | 70 | 3 | M27522 | |
| Pathway | REACTOME_PI_3K_CASCADE_FGFR2 | 1.69e-04 | 22 | 70 | 3 | MM15240 | |
| Pathway | REACTOME_PI_3K_CASCADE_FGFR2 | 1.93e-04 | 23 | 70 | 3 | M27514 | |
| Pathway | REACTOME_FRS_MEDIATED_FGFR2_SIGNALING | 1.93e-04 | 23 | 70 | 3 | MM15243 | |
| Pathway | REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR3 | 2.20e-04 | 24 | 70 | 3 | MM15246 | |
| Pathway | REACTOME_FRS_MEDIATED_FGFR2_SIGNALING | 2.49e-04 | 25 | 70 | 3 | M27517 | |
| Pathway | REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR3 | 2.49e-04 | 25 | 70 | 3 | M27520 | |
| Pathway | REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR4 | 2.81e-04 | 26 | 70 | 3 | MM15249 | |
| Pathway | REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR4 | 3.15e-04 | 27 | 70 | 3 | M27523 | |
| Pathway | KEGG_MEDICUS_REFERENCE_IL6_FAMILY_TO_JAK_STAT_SIGNALING_PATHWAY | 3.15e-04 | 27 | 70 | 3 | M47906 | |
| Pathway | REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR2 | 3.51e-04 | 28 | 70 | 3 | MM15241 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_FGFR3_SIGNALING | 3.91e-04 | 29 | 70 | 3 | M27528 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_FGFR3_SIGNALING | 3.91e-04 | 29 | 70 | 3 | MM15253 | |
| Pathway | REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR2 | 4.32e-04 | 30 | 70 | 3 | M27515 | |
| Pathway | PID_CDC42_REG_PATHWAY | 4.32e-04 | 30 | 70 | 3 | M83 | |
| Pathway | KEGG_MEDICUS_REFERENCE_FGF_FGFR_PI3K_SIGNALING_PATHWAY | 4.77e-04 | 31 | 70 | 3 | M47396 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_FGFR4_SIGNALING | 4.77e-04 | 31 | 70 | 3 | M27529 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_FGFR4_SIGNALING | 4.77e-04 | 31 | 70 | 3 | MM15254 | |
| Pathway | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | 4.77e-04 | 31 | 70 | 3 | M877 | |
| Pathway | REACTOME_FGFR3B_LIGAND_BINDING_AND_ACTIVATION | 5.02e-04 | 7 | 70 | 2 | M27064 | |
| Pathway | REACTOME_FGFR3B_LIGAND_BINDING_AND_ACTIVATION | 5.02e-04 | 7 | 70 | 2 | MM14726 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_FGFR2_SIGNALING | 5.75e-04 | 33 | 70 | 3 | MM15252 | |
| Pathway | REACTOME_FGFR2_MUTANT_RECEPTOR_ACTIVATION | 5.75e-04 | 33 | 70 | 3 | M27049 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_FGFR2_SIGNALING | 6.28e-04 | 34 | 70 | 3 | M27527 | |
| Pathway | KEGG_MEDICUS_REFERENCE_FGF_FGFR_RAS_ERK_SIGNALING_PATHWAY | 6.85e-04 | 35 | 70 | 3 | M47379 | |
| Pathway | REACTOME_CLATHRIN_MEDIATED_ENDOCYTOSIS | 6.92e-04 | 142 | 70 | 5 | MM15499 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING | 7.30e-04 | 302 | 70 | 7 | M39719 | |
| Pathway | REACTOME_CLATHRIN_MEDIATED_ENDOCYTOSIS | 7.60e-04 | 145 | 70 | 5 | M27753 | |
| Pathway | REACTOME_INTERLEUKIN_27_SIGNALING | 8.56e-04 | 9 | 70 | 2 | MM15620 | |
| Pathway | REACTOME_SIGNALING_BY_FGFR3 | 9.43e-04 | 39 | 70 | 3 | MM15257 | |
| Pathway | REACTOME_MAPK_FAMILY_SIGNALING_CASCADES | 9.88e-04 | 318 | 70 | 7 | MM15278 | |
| Pathway | REACTOME_SIGNALING_BY_FGFR3 | 1.02e-03 | 40 | 70 | 3 | M27532 | |
| Pathway | REACTOME_SIGNALING_BY_FGFR4 | 1.02e-03 | 40 | 70 | 3 | MM15258 | |
| Pathway | REACTOME_SIGNALING_BY_FGFR4 | 1.09e-03 | 41 | 70 | 3 | M27533 | |
| Pathway | REACTOME_IRS_MEDIATED_SIGNALLING | 1.09e-03 | 41 | 70 | 3 | MM14505 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTOR_SIGNALING_PATHWAY | 1.14e-03 | 326 | 70 | 7 | MM15917 | |
| Pathway | REACTOME_MAPK_FAMILY_SIGNALING_CASCADES | 1.16e-03 | 327 | 70 | 7 | M27565 | |
| Pathway | REACTOME_SIGNALING_BY_FGFR2_IN_DISEASE | 1.26e-03 | 43 | 70 | 3 | M27534 | |
| Pathway | REACTOME_SIGNALING_BY_ACTIVATED_POINT_MUTANTS_OF_FGFR1 | 1.30e-03 | 11 | 70 | 2 | M675 | |
| Pathway | KEGG_MEDICUS_REFERENCE_N_GLYCAN_PRECURSOR_BIOSYNTHESIS_ALG6_TO_OST | 1.30e-03 | 11 | 70 | 2 | M47614 | |
| Pathway | REACTOME_INTERLEUKIN_27_SIGNALING | 1.30e-03 | 11 | 70 | 2 | M27897 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CYTOKINE_JAK_STAT_SIGNALING_PATHWAY | 1.43e-03 | 45 | 70 | 3 | M47408 | |
| Pathway | REACTOME_SIGNALING_BY_TYPE_1_INSULIN_LIKE_GROWTH_FACTOR_1_RECEPTOR_IGF1R | 1.63e-03 | 47 | 70 | 3 | MM14885 | |
| Pathway | REACTOME_CARGO_RECOGNITION_FOR_CLATHRIN_MEDIATED_ENDOCYTOSIS | 1.64e-03 | 102 | 70 | 4 | MM15498 | |
| Pathway | REACTOME_IRS_MEDIATED_SIGNALLING | 1.73e-03 | 48 | 70 | 3 | M26916 | |
| Pathway | REACTOME_INSULIN_RECEPTOR_SIGNALLING_CASCADE | 1.73e-03 | 48 | 70 | 3 | MM15441 | |
| Pathway | REACTOME_CARGO_RECOGNITION_FOR_CLATHRIN_MEDIATED_ENDOCYTOSIS | 1.83e-03 | 105 | 70 | 4 | M27752 | |
| Pathway | KEGG_CIRCADIAN_RHYTHM_MAMMAL | 1.83e-03 | 13 | 70 | 2 | M18009 | |
| Pathway | REACTOME_FGFR1C_LIGAND_BINDING_AND_ACTIVATION | 1.83e-03 | 13 | 70 | 2 | MM14727 | |
| Pathway | REACTOME_HEME_SIGNALING | 1.83e-03 | 49 | 70 | 3 | M41832 | |
| Pathway | REACTOME_INTERLEUKIN_4_AND_INTERLEUKIN_13_SIGNALING | 2.13e-03 | 14 | 70 | 2 | MM15321 | |
| Pathway | REACTOME_FGFR1C_LIGAND_BINDING_AND_ACTIVATION | 2.13e-03 | 14 | 70 | 2 | M27065 | |
| Pathway | REACTOME_SIGNALING_BY_TYPE_1_INSULIN_LIKE_GROWTH_FACTOR_1_RECEPTOR_IGF1R | 2.43e-03 | 54 | 70 | 3 | M27168 | |
| Pathway | REACTOME_INSULIN_RECEPTOR_SIGNALLING_CASCADE | 2.43e-03 | 54 | 70 | 3 | M620 | |
| Pathway | WP_RUBINSTEINTAYBI_SYNDROME_1 | 2.45e-03 | 15 | 70 | 2 | M48323 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RTK_PLCG_ITPR_SIGNALING_PATHWAY | 2.56e-03 | 55 | 70 | 3 | M47952 | |
| Pathway | WP_ESC_PLURIPOTENCY_PATHWAYS | 2.63e-03 | 116 | 70 | 4 | MM15863 | |
| Pathway | WP_EMBRYONIC_STEM_CELL_PLURIPOTENCY_PATHWAYS | 2.71e-03 | 117 | 70 | 4 | M39530 | |
| Pathway | REACTOME_PHOSPHOLIPASE_C_MEDIATED_CASCADE_FGFR1 | 2.79e-03 | 16 | 70 | 2 | M48007 | |
| Pathway | PID_CIRCADIAN_PATHWAY | 2.79e-03 | 16 | 70 | 2 | M95 | |
| Pathway | REACTOME_IL_6_TYPE_CYTOKINE_RECEPTOR_LIGAND_INTERACTIONS | 2.79e-03 | 16 | 70 | 2 | MM15323 | |
| Pathway | REACTOME_INTERLEUKIN_12_FAMILY_SIGNALING | 2.79e-03 | 16 | 70 | 2 | MM15127 | |
| Pathway | REACTOME_PHOSPHOLIPASE_C_MEDIATED_CASCADE_FGFR1 | 2.79e-03 | 16 | 70 | 2 | MM15233 | |
| Pathway | REACTOME_FGFR1_LIGAND_BINDING_AND_ACTIVATION | 3.15e-03 | 17 | 70 | 2 | MM17066 | |
| Pathway | REACTOME_IL_6_TYPE_CYTOKINE_RECEPTOR_LIGAND_INTERACTIONS | 3.15e-03 | 17 | 70 | 2 | M27612 | |
| Pathway | REACTOME_ABC_TRANSPORTERS_IN_LIPID_HOMEOSTASIS | 3.15e-03 | 17 | 70 | 2 | MM14552 | |
| Pathway | REACTOME_FGFR1_LIGAND_BINDING_AND_ACTIVATION | 3.53e-03 | 18 | 70 | 2 | M1092 | |
| Pathway | REACTOME_ABC_TRANSPORTERS_IN_LIPID_HOMEOSTASIS | 3.53e-03 | 18 | 70 | 2 | M524 | |
| Pathway | REACTOME_SIGNALING_BY_FGFR2 | 3.60e-03 | 62 | 70 | 3 | MM15256 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 3.76e-03 | 63 | 70 | 3 | M11187 | |
| Pathway | REACTOME_SIGNALING_BY_FGFR_IN_DISEASE | 3.76e-03 | 63 | 70 | 3 | M635 | |
| Pathway | PID_IL4_2PATHWAY | 3.93e-03 | 64 | 70 | 3 | M28 | |
| Pathway | REACTOME_SCAVENGING_BY_CLASS_A_RECEPTORS | 3.94e-03 | 19 | 70 | 2 | M27221 | |
| Pathway | KEGG_CELL_ADHESION_MOLECULES_CAMS | 4.29e-03 | 133 | 70 | 4 | M16476 | |
| Pathway | REACTOME_SHC_MEDIATED_CASCADE_FGFR1 | 4.36e-03 | 20 | 70 | 2 | MM15237 | |
| Pathway | REACTOME_PI_3K_CASCADE_FGFR1 | 4.80e-03 | 21 | 70 | 2 | M27512 | |
| Pathway | REACTOME_SHC_MEDIATED_CASCADE_FGFR1 | 4.80e-03 | 21 | 70 | 2 | M27511 | |
| Pathway | REACTOME_PI_3K_CASCADE_FGFR1 | 4.80e-03 | 21 | 70 | 2 | MM15238 | |
| Pubmed | Roles of the DOCK-D family proteins in a mouse model of neuroinflammation. | 2.17e-08 | 3 | 98 | 3 | 32241915 | |
| Pubmed | 2.16e-07 | 5 | 98 | 3 | 15710388 | ||
| Pubmed | The RhoGEF DOCK10 is essential for dendritic spine morphogenesis. | 4.31e-07 | 6 | 98 | 3 | 25851601 | |
| Pubmed | Fgf16 is required for cardiomyocyte proliferation in the mouse embryonic heart. | 7.53e-07 | 7 | 98 | 3 | 18816849 | |
| Pubmed | 2.57e-06 | 10 | 98 | 3 | 15621532 | ||
| Pubmed | 7.72e-06 | 14 | 98 | 3 | 12432077 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 18066066 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 25483786 | ||
| Pubmed | cDNA cloning and characterization of the human interleukin 13 receptor alpha chain. | 7.86e-06 | 2 | 98 | 2 | 8910586 | |
| Pubmed | Coassociation of CD26 (dipeptidyl peptidase IV) with CD45 on the surface of human T lymphocytes. | 7.86e-06 | 2 | 98 | 2 | 1680916 | |
| Pubmed | Angiotensin II Stimulation of DPP4 Activity Regulates Megalin in the Proximal Tubules. | 7.86e-06 | 2 | 98 | 2 | 27213360 | |
| Pubmed | Single cell analysis of ligand binding and complex formation of interleukin-4 receptor subunits. | 7.86e-06 | 2 | 98 | 2 | 22098734 | |
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 26088753 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 19564416 | ||
| Pubmed | Association of CD26 with CD45RA outside lipid rafts attenuates cord blood T-cell activation. | 7.86e-06 | 2 | 98 | 2 | 14525771 | |
| Pubmed | Truncated apo B-70.5-containing lipoproteins bind to megalin but not the LDL receptor. | 7.86e-06 | 2 | 98 | 2 | 10330424 | |
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 26187331 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 33419470 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 29099971 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 25729399 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 8552669 | ||
| Pubmed | Association between restless legs syndrome and CLOCK and NPAS2 gene polymorphisms in schizophrenia. | 7.86e-06 | 2 | 98 | 2 | 24824748 | |
| Pubmed | 9.63e-06 | 15 | 98 | 3 | 22962329 | ||
| Pubmed | 1.68e-05 | 54 | 98 | 4 | 20536507 | ||
| Pubmed | Receptor specificity of the fibroblast growth factor family. The complete mammalian FGF family. | 2.03e-05 | 19 | 98 | 3 | 16597617 | |
| Pubmed | 2.09e-05 | 57 | 98 | 4 | 19263529 | ||
| Pubmed | 2.09e-05 | 57 | 98 | 4 | 19479237 | ||
| Pubmed | 2.35e-05 | 3 | 98 | 2 | 24303013 | ||
| Pubmed | Circadian clock proteins regulate neuronal redox homeostasis and neurodegeneration. | 2.35e-05 | 3 | 98 | 2 | 24270424 | |
| Pubmed | CLOCK and NPAS2 have overlapping roles in the suprachiasmatic circadian clock. | 2.35e-05 | 3 | 98 | 2 | 17417633 | |
| Pubmed | Polymorphisms in the IL13, IL13RA1, and IL4RA genes and rate of decline in lung function in smokers. | 2.35e-05 | 3 | 98 | 2 | 12594065 | |
| Pubmed | Circadian variation of blood pressure and the vascular response to asynchronous stress. | 2.35e-05 | 3 | 98 | 2 | 17360665 | |
| Pubmed | 2.35e-05 | 3 | 98 | 2 | 17264841 | ||
| Pubmed | 2.35e-05 | 3 | 98 | 2 | 26134245 | ||
| Pubmed | Role of IL-4 in bone marrow driven dysregulated angiogenesis and age-related macular degeneration. | 2.35e-05 | 3 | 98 | 2 | 32366355 | |
| Pubmed | NPAS2 Compensates for Loss of CLOCK in Peripheral Circadian Oscillators. | 2.35e-05 | 3 | 98 | 2 | 26895328 | |
| Pubmed | 2.35e-05 | 3 | 98 | 2 | 17637349 | ||
| Pubmed | Regulation of clock and NPAS2 DNA binding by the redox state of NAD cofactors. | 2.35e-05 | 3 | 98 | 2 | 11441146 | |
| Pubmed | On the Role IL-4/IL-13 Heteroreceptor Plays in Regulation of Type 1 Diabetes. | 2.35e-05 | 3 | 98 | 2 | 28646042 | |
| Pubmed | Breast cancer risk, nightwork, and circadian clock gene polymorphisms. | 2.35e-05 | 3 | 98 | 2 | 24919398 | |
| Pubmed | Examining the role of ABC lipid transporters in pulmonary lipid homeostasis and inflammation. | 2.35e-05 | 3 | 98 | 2 | 28241820 | |
| Pubmed | 3.21e-05 | 22 | 98 | 3 | 11900978 | ||
| Pubmed | Klf2 is an essential regulator of vascular hemodynamic forces in vivo. | 3.21e-05 | 22 | 98 | 3 | 17141159 | |
| Pubmed | 3.21e-05 | 22 | 98 | 3 | 26748348 | ||
| Pubmed | 3.31e-05 | 64 | 98 | 4 | 19131662 | ||
| Pubmed | 3.52e-05 | 65 | 98 | 4 | 23453885 | ||
| Pubmed | 3.69e-05 | 23 | 98 | 3 | 14517998 | ||
| Pubmed | Genome-wide association study identifies five new schizophrenia loci. | 3.69e-05 | 23 | 98 | 3 | 21926974 | |
| Pubmed | 3.69e-05 | 23 | 98 | 3 | 23322300 | ||
| Pubmed | 3.69e-05 | 23 | 98 | 3 | 20713518 | ||
| Pubmed | 4.70e-05 | 4 | 98 | 2 | 22245779 | ||
| Pubmed | 4.70e-05 | 4 | 98 | 2 | 24143212 | ||
| Pubmed | 4.70e-05 | 4 | 98 | 2 | 29671710 | ||
| Pubmed | 4.70e-05 | 4 | 98 | 2 | 33767712 | ||
| Pubmed | Neutrophilic granulocytes modulate invariant NKT cell function in mice and humans. | 4.70e-05 | 4 | 98 | 2 | 22387552 | |
| Pubmed | Tau Reduction Prevents Key Features of Autism in Mouse Models. | 4.70e-05 | 4 | 98 | 2 | 32126198 | |
| Pubmed | 4.70e-05 | 4 | 98 | 2 | 16424049 | ||
| Pubmed | The IKr drug response is modulated by KCR1 in transfected cardiac and noncardiac cell lines. | 4.70e-05 | 4 | 98 | 2 | 14525949 | |
| Pubmed | 4.70e-05 | 4 | 98 | 2 | 19829696 | ||
| Pubmed | 4.70e-05 | 4 | 98 | 2 | 22144566 | ||
| Pubmed | 4.70e-05 | 4 | 98 | 2 | 23818941 | ||
| Pubmed | A mouse carrying genetic defect in the choice between T and B lymphocytes. | 4.70e-05 | 4 | 98 | 2 | 9794386 | |
| Pubmed | Genetic components of the circadian clock regulate thrombogenesis in vivo. | 4.70e-05 | 4 | 98 | 2 | 18413500 | |
| Pubmed | Molecular and structural basis of cytokine receptor pleiotropy in the interleukin-4/13 system. | 4.70e-05 | 4 | 98 | 2 | 18243101 | |
| Pubmed | ARNTL (BMAL1) and NPAS2 gene variants contribute to fertility and seasonality. | 4.70e-05 | 4 | 98 | 2 | 20368993 | |
| Pubmed | Expression of interleukin-4 and interleukin-13 and their receptors in colorectal cancer. | 4.70e-05 | 4 | 98 | 2 | 22441356 | |
| Pubmed | FGF signaling directs a center-to-pole expansion of tubulogenesis in mouse testis differentiation. | 4.77e-05 | 25 | 98 | 3 | 20040496 | |
| Pubmed | Expression of Fgf signalling pathway related genes during palatal rugae development in the mouse. | 5.38e-05 | 26 | 98 | 3 | 20348033 | |
| Pubmed | 6.04e-05 | 27 | 98 | 3 | 19544582 | ||
| Pubmed | 7.52e-05 | 29 | 98 | 3 | 21876757 | ||
| Pubmed | 7.82e-05 | 5 | 98 | 2 | 21913997 | ||
| Pubmed | 7.82e-05 | 5 | 98 | 2 | 22376040 | ||
| Pubmed | Characterization of the mouse interleukin-13 receptor alpha1 gene. | 7.82e-05 | 5 | 98 | 2 | 11003391 | |
| Pubmed | 7.82e-05 | 5 | 98 | 2 | 21633705 | ||
| Pubmed | 7.82e-05 | 5 | 98 | 2 | 18852293 | ||
| Pubmed | 7.82e-05 | 5 | 98 | 2 | 11439184 | ||
| Pubmed | Organogenesis of the liver, thymus and spleen is affected in jumonji mutant mice. | 7.82e-05 | 5 | 98 | 2 | 9376320 | |
| Pubmed | 7.82e-05 | 5 | 98 | 2 | 27438770 | ||
| Pubmed | Genetic mapping of the gene encoding the alpha1 subunit of neuronal calcium channels. | 7.82e-05 | 5 | 98 | 2 | 8661716 | |
| Pubmed | 7.82e-05 | 5 | 98 | 2 | 18316400 | ||
| Pubmed | 7.82e-05 | 5 | 98 | 2 | 11276432 | ||
| Pubmed | CLOCK gene variants associate with sleep duration in two independent populations. | 7.82e-05 | 5 | 98 | 2 | 20149345 | |
| Pubmed | 7.82e-05 | 5 | 98 | 2 | 11313257 | ||
| Pubmed | 7.82e-05 | 5 | 98 | 2 | 17436251 | ||
| Pubmed | 9.21e-05 | 31 | 98 | 3 | 16123981 | ||
| Pubmed | DPP4 NAA15 DOCK9 DOCK10 ASPHD2 MDN1 PTPRC PIK3C2A OASL ATP13A3 IL6ST STEAP1 | 1.11e-04 | 1168 | 98 | 12 | 19946888 | |
| Pubmed | 1.11e-04 | 33 | 98 | 3 | 19028820 | ||
| Pubmed | 1.11e-04 | 33 | 98 | 3 | 18974840 | ||
| Pubmed | 1.17e-04 | 6 | 98 | 2 | 28801358 | ||
| Pubmed | Genetic mapping of mouse tumor necrosis factor-alpha converting enzyme (TACE) to chromosome 12. | 1.17e-04 | 6 | 98 | 2 | 9598327 | |
| Pubmed | 1.17e-04 | 6 | 98 | 2 | 27421703 | ||
| Pubmed | 1.17e-04 | 6 | 98 | 2 | 33549845 | ||
| Pubmed | 1.17e-04 | 6 | 98 | 2 | 17182563 | ||
| Pubmed | LncRNAs-directed PTEN enzymatic switch governs epithelial-mesenchymal transition. | 1.17e-04 | 168 | 98 | 5 | 30631154 | |
| Pubmed | 1.22e-04 | 34 | 98 | 3 | 20603037 | ||
| Pubmed | Systematic screening for skin, hair, and nail abnormalities in a large-scale knockout mouse program. | 1.27e-04 | 171 | 98 | 5 | 28700664 | |
| Pubmed | Postnatal prolongation of mammalian nephrogenesis by excess fetal GDNF. | 1.33e-04 | 35 | 98 | 3 | 34032268 | |
| Pubmed | 1.49e-04 | 94 | 98 | 4 | 25201988 | ||
| Pubmed | C to U RNA editing mediated by APOBEC1 requires RNA-binding protein RBM47. | 1.64e-04 | 7 | 98 | 2 | 24916387 | |
| Pubmed | Polygenic dissection of diagnosis and clinical dimensions of bipolar disorder and schizophrenia. | 1.64e-04 | 7 | 98 | 2 | 24280982 | |
| Cytoband | Xq24 | 3.58e-04 | 64 | 98 | 3 | Xq24 | |
| Cytoband | 2q24.3 | 5.31e-04 | 16 | 98 | 2 | 2q24.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chrXq24 | 7.13e-04 | 81 | 98 | 3 | chrXq24 | |
| GeneFamily | Alpha-1,2-glucosyltransferases | 1.79e-05 | 2 | 77 | 2 | 448 | |
| GeneFamily | Fibronectin type III domain containing | 6.17e-05 | 160 | 77 | 6 | 555 | |
| GeneFamily | CD molecules|I-set domain containing|Immunoglobulin like domain containing|Interleukin receptors|TIR domain containing | 7.57e-04 | 42 | 77 | 3 | 602 | |
| GeneFamily | Progestin and adipoQ receptor family | 9.60e-04 | 11 | 77 | 2 | 930 | |
| GeneFamily | Ankyrin repeat domain containing|FERM domain containing | 1.26e-03 | 50 | 77 | 3 | 1293 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 1.44e-03 | 394 | 77 | 7 | 471 | |
| GeneFamily | Proteases, serine | 2.45e-03 | 63 | 77 | 3 | 738 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 4.95e-03 | 161 | 77 | 4 | 593 | |
| Coexpression | GSE25087_FETAL_VS_ADULT_TREG_DN | 6.42e-07 | 192 | 98 | 8 | M4643 | |
| Coexpression | GSE40685_TREG_VS_FOXP3_KO_TREG_PRECURSOR_UP | 1.01e-05 | 199 | 98 | 7 | M9306 | |
| Coexpression | GSE16385_ROSIGLITAZONE_IL4_VS_IL4_ALONE_STIM_MACROPHAGE_12H_UP | 1.04e-05 | 200 | 98 | 7 | M8026 | |
| Coexpression | LAKE_ADULT_KIDNEY_C22_ENDOTHELIAL_CELLS_GLOMERULAR_CAPILLARIES | 1.30e-05 | 137 | 98 | 6 | M39241 | |
| Coexpression | LAKE_ADULT_KIDNEY_C28_INTERSTITIUM | 1.81e-05 | 86 | 98 | 5 | M39247 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.02e-10 | 184 | 98 | 9 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.02e-10 | 184 | 98 | 9 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.02e-10 | 184 | 98 | 9 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Granulocytic-Neutrophil-Neu_c4-RSAD2|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.59e-08 | 156 | 98 | 7 | f5889a6899904dfb7f596600b3a76857cf9d5378 | |
| ToppCell | Tuft-tuft-4|World / Class top | 1.18e-07 | 174 | 98 | 7 | d6f306ebf66061bf9e9742000bfedce12d277452 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_alveolar-distal|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.30e-07 | 192 | 98 | 7 | b7c01e12b3e9be960a741b08835f1dfff65d0d47 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^medium_distal_(2)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.38e-07 | 193 | 98 | 7 | 4b8202fcfe639a73f69a13f48fc3601ade256346 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.56e-07 | 195 | 98 | 7 | 818bc18c5834238e5f733cac6fe928ed0788f57d | |
| ToppCell | COVID-19-lung|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.93e-07 | 199 | 98 | 7 | 155b03b859157013e9142e9248551369127d9204 | |
| ToppCell | LPS-IL1RA-Lymphocytic_NKT-T_cells-Erythroid|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.00e-07 | 128 | 98 | 6 | c2045f052cc713e52312eb015825711576fcb6c5 | |
| ToppCell | Ciliated_cells-B-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 1.71e-06 | 164 | 98 | 6 | fd30c55d0d75ef8b9396435d836187168095152b | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_vein-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.90e-06 | 167 | 98 | 6 | d7fe24cdc4b55a9555ce9e20699f5036b88148e9 | |
| ToppCell | Control-Endothelial_cells-Systemic_venous_endothelial_cells|Control / group, cell type (main and fine annotations) | 2.25e-06 | 172 | 98 | 6 | c55dce1ed3ed7312394b4e050e1de852a994e130 | |
| ToppCell | LPS_only-Lymphocytic_NKT-T_cells-T-cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.93e-06 | 180 | 98 | 6 | dcef253f2e97e4436b1b04e8a06a53ff6e64522c | |
| ToppCell | LPS_only-Lymphocytic_NKT-T_cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.02e-06 | 181 | 98 | 6 | a4347ae554e6dcf03c7001a2b69332b377c7c034 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.12e-06 | 182 | 98 | 6 | ed6ae0fd8653f213fe29906a6a4e0729a62e1b75 | |
| ToppCell | COVID-19-Heart-EC_3|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.22e-06 | 183 | 98 | 6 | ff95382cfed592190d0636d2b750328471f82e0d | |
| ToppCell | COVID-19-kidney-PCT-S1|kidney / Disease (COVID-19 only), tissue and cell type | 3.32e-06 | 184 | 98 | 6 | 51ed1ebfdef45149541917c66cbacad87072e51f | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 3.32e-06 | 184 | 98 | 6 | fa4915b0498f3069fd5ef497286445528f75187e | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.43e-06 | 185 | 98 | 6 | 5e689c2fb36ce3ac2adc8d15f67107f21cf68868 | |
| ToppCell | 15-Airway-Epithelial-Multiciliated_cell|Airway / Age, Tissue, Lineage and Cell class | 3.43e-06 | 185 | 98 | 6 | 0998b6bf44287eebbf39249fff23fc3689e44c4e | |
| ToppCell | Adult-Epithelial-ciliated_cell-D175|Adult / Lineage, Cell type, age group and donor | 3.43e-06 | 185 | 98 | 6 | 30f4980dee6cd5959655f8d74049f3bfb5312611 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_ciliated|COVID-19 / group, cell type (main and fine annotations) | 3.43e-06 | 185 | 98 | 6 | 18a40f0a338aa398d81384b5159fb80ce8a2020c | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.54e-06 | 186 | 98 | 6 | bb0bfe9a015151be08a6ffc5d82896d0556d76de | |
| ToppCell | COVID-19-kidney-Fibroblast-1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.65e-06 | 187 | 98 | 6 | 76bfe8c42430a230a8bdf299575c444fb7780f24 | |
| ToppCell | COVID-19-kidney-tDL|kidney / Disease (COVID-19 only), tissue and cell type | 3.65e-06 | 187 | 98 | 6 | d35d27ca3c0e65f92f4508e1cb98a743f44fdcdf | |
| ToppCell | Epithelial-ciliated_cell|World / Lineage, Cell type, age group and donor | 3.76e-06 | 188 | 98 | 6 | 61a459f3fe57e5728efc72637ff2edc2d343492b | |
| ToppCell | Macrophages-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 3.88e-06 | 189 | 98 | 6 | c05b4b565c0ce56dbb45fc9503654a2ec1a7e1e9 | |
| ToppCell | Adult-Epithelial-ciliated_cell|Adult / Lineage, Cell type, age group and donor | 3.88e-06 | 189 | 98 | 6 | b679920f0993e917dd86da082113bfbd85ea1ca5 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.00e-06 | 190 | 98 | 6 | 1121eb607a984c59fbffe7220837fc178745aa55 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.00e-06 | 190 | 98 | 6 | 048b581e3f7ea9fc2f87c0532974bba85c7292c2 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 4.00e-06 | 190 | 98 | 6 | 625c08a0e5227efc46daa512fd579c3938ff76c7 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.00e-06 | 190 | 98 | 6 | 45df8fee00f8949937863159d7aa042e72748d9b | |
| ToppCell | human_hepatoblastoma-Inflammatory_Monocytes|World / Sample and Cell Type and Tumor Cluster (all cells) | 4.12e-06 | 191 | 98 | 6 | 3b59bfc6c106ae8a3fbcd4a74bd128c485724921 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.12e-06 | 191 | 98 | 6 | 08720998aa55131d7377c4c67c4c935865bd7d79 | |
| ToppCell | severe_influenza-B_naive|severe_influenza / disease group, cell group and cell class (v2) | 4.50e-06 | 194 | 98 | 6 | 7c1e9ce5de3bb1657a67010de673c8bb60129cb6 | |
| ToppCell | Bronchial-NucSeq-Endothelial-Endothelia_vascular-VE_systemic_venous|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.64e-06 | 195 | 98 | 6 | fde8e7b38b3631109b95ef111c5f6e3f9878cfbd | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^medium_distal_(2)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 4.64e-06 | 195 | 98 | 6 | f08e41706680881ebd0afcd08a02f8ac0089f04e | |
| ToppCell | human_hepatoblastoma-Inflammatory_Monocytes|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 4.64e-06 | 195 | 98 | 6 | ba7f85e5307d96ac5ad7c952f8d094db9ca1790c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.78e-06 | 196 | 98 | 6 | 7cbb19108b4553ef60ef5c230a29de1662c02efe | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.78e-06 | 196 | 98 | 6 | 4cd1e6b7a791e11a40b19f971b7011bd11fe6273 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Myofibroblastic-Muscle_perivascular_immune_recruiting|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.92e-06 | 197 | 98 | 6 | 3332b9b5bf78f0203ebbd94257a36e9054d896c3 | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Macrophage_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.06e-06 | 198 | 98 | 6 | e125eb8aa57c172e5518874da1bd25998292f5e2 | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Macrophage_alveolar-Macro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.06e-06 | 198 | 98 | 6 | 0baeb8e2c199ff10bb5c829c523546af3c9227c1 | |
| ToppCell | Tracheal-NucSeq-Endothelial-Endothelia_vascular-VE_systemic_venous|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.06e-06 | 198 | 98 | 6 | 5c82dad416938d5c460069796d808170e7dbc8d9 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.06e-06 | 198 | 98 | 6 | a860246bcea847249a78fd2e86ed8e04371060db | |
| ToppCell | Tracheal-NucSeq-Endothelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.06e-06 | 198 | 98 | 6 | 77e31b6edeeb5ccd5cd3f080898c96bf9ab9f98d | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Syt6-Excitatory_Neuron.Slc17a7.Syt6-Slc30a3_(Deep_layer_pyramidal_cells)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 5.29e-06 | 52 | 98 | 4 | 106dd69be38d8ebd298d825c14ac0eefd8366a1a | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Syt6-Excitatory_Neuron.Slc17a7.Syt6-Slc30a3_(Deep_layer_pyramidal_cells)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 5.29e-06 | 52 | 98 | 4 | 9eaf9c1276a3e074cf6c476a419546cbbe4d525c | |
| ToppCell | Biopsy_Other_PF-Epithelial-Differentiating_Ciliated|Biopsy_Other_PF / Sample group, Lineage and Cell type | 5.36e-06 | 200 | 98 | 6 | f7b4581d958afbd68f9045af619aaca0ab463439 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_ciliated-Ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.36e-06 | 200 | 98 | 6 | 926a7ea94b5908aebf103893ea83ce9d25285b65 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_ciliated-Ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.36e-06 | 200 | 98 | 6 | af6a551f83808c1c839df7ba7b1702ca28ea6e1b | |
| ToppCell | Influenza-Influenza_Severe-Lymphocyte-B-B_naive|Influenza_Severe / Disease, condition lineage and cell class | 5.36e-06 | 200 | 98 | 6 | 0e05600d725dc5cc9afccc11eedc60efa41e4e46 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.36e-06 | 200 | 98 | 6 | 73ac1cf40ddd764be1100cbfaaa29563665457d8 | |
| ToppCell | severe-B_naive|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.36e-06 | 200 | 98 | 6 | 0e86f52b6e146d9bbc728d8fb176fc2b53696558 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.36e-06 | 200 | 98 | 6 | 06ce6e03498ba38ef6a06eaf2731e3b2eeda59eb | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma-Myxofibrosarcoma|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 1.06e-05 | 131 | 98 | 5 | c847dcdfb94feb9e1dfc072a162d2b1b6f3d59e4 | |
| ToppCell | 3'_v3-blood-Lymphocytic_T_CD8-Trm_gut_CD8|blood / Manually curated celltypes from each tissue | 2.17e-05 | 152 | 98 | 5 | 1fea735321da6db6d2cd3f83d2f7fac72d44904d | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-chondrocyte-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.24e-05 | 153 | 98 | 5 | 65641cc82883716dba0fefb749a30174a63f4da5 | |
| ToppCell | E16.5-samps-Epithelial-Alveolar_epithelial_precursor-Noncycling_AT2_Precursor|E16.5-samps / Age Group, Lineage, Cell class and subclass | 2.39e-05 | 155 | 98 | 5 | 9cad73d0b8ead289e1073d1a2e00bbeb1228308c | |
| ToppCell | 18-Airway-Epithelial-Bud_tip_progenitor|Airway / Age, Tissue, Lineage and Cell class | 2.70e-05 | 159 | 98 | 5 | e715cadff8e7d5ebe4c2198dbdfd3ca41ecb8a6a | |
| ToppCell | RV-13._Vascular_Smooth_Muscle|RV / Chamber and Cluster_Paper | 2.86e-05 | 161 | 98 | 5 | 47b3b7662cbb671ccc086dc0a0cabd65f63eb5a1 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_bronchial_vessel|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.04e-05 | 163 | 98 | 5 | 977a970b1296234c22178420294cea73506ee02f | |
| ToppCell | 10x5'-GI_large-bowel-Lymphocytic_T_CD4-Tfh|GI_large-bowel / Manually curated celltypes from each tissue | 3.04e-05 | 163 | 98 | 5 | 4104d3b9748b39cb0744c9be76db21bdda566a0d | |
| ToppCell | Thalamus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Six3-Inhibitory_Neuron.Gad1Gad2.Six3-Sst_(Reticular_formation)|Thalamus / BrainAtlas - Mouse McCarroll V32 | 3.10e-05 | 81 | 98 | 4 | 717751c7a6af08cec7d0e561869e4b292d1f83a5 | |
| ToppCell | Thalamus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Six3-Inhibitory_Neuron.Gad1Gad2.Six3-Sst_(Reticular_formation)-|Thalamus / BrainAtlas - Mouse McCarroll V32 | 3.10e-05 | 81 | 98 | 4 | e58f07266b7bad0af9a9856c678b4e0850c9f6c9 | |
| ToppCell | Basal_cells-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 3.31e-05 | 166 | 98 | 5 | 23c04d1fba0c1733ccd0e4378fae2edde4fd0a7b | |
| ToppCell | PBMC-Control-Hematopoietic-Platelet-Platelet-plt_4|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.51e-05 | 168 | 98 | 5 | 2d056cfbb470a088a0682576753535fb4528d48f | |
| ToppCell | E16.5-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated-Ciliated_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.51e-05 | 168 | 98 | 5 | fa7c0303918cea04e3f4c4f3cb079be19004d214 | |
| ToppCell | PBMC-Control-Hematopoietic-Platelet-Platelet-plt_4|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.51e-05 | 168 | 98 | 5 | 2f69e248c6fab1421c0081e01e1920e6ffcde344 | |
| ToppCell | E16.5-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.51e-05 | 168 | 98 | 5 | 7edcab103c69e928d5c19a0d218ffb3ae32f9e70 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.61e-05 | 169 | 98 | 5 | 14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f | |
| ToppCell | Ciliated_cells-A-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 3.71e-05 | 170 | 98 | 5 | 8b7ef1464ea589886b575ebad5447b085cbdcdba | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_mature-Endo_capilar-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.93e-05 | 172 | 98 | 5 | c3a99828838af3b85c8c885d69cc8018f55ced50 | |
| ToppCell | 3'_v3-blood-Lymphocytic_B-Naive_B_cells|blood / Manually curated celltypes from each tissue | 3.93e-05 | 172 | 98 | 5 | f16f90d17feac1ee52fd513907b28456865fd31d | |
| ToppCell | Children_(3_yrs)-Mesenchymal-vascular_smooth_muscle_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.03e-05 | 173 | 98 | 5 | 5416b092321c7d9b63f0418c60f2402a138355bf | |
| ToppCell | Ciliated_cells-A-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 4.38e-05 | 176 | 98 | 5 | 1c364155f46b9a7c995bdc2cc2333c437cd90f5b | |
| ToppCell | LPS-IL1RA+antiTNF-Lymphocytic_NKT-T_cells-T-cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.38e-05 | 176 | 98 | 5 | 9d4a4dfeebb5a8a0f3ab18c37c8ddc2cd2158575 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 4.38e-05 | 176 | 98 | 5 | 2e94bbe17c0bb65dc58b4ebc0cb829258bd7373b | |
| ToppCell | LPS-IL1RA+antiTNF-Lymphocytic_NKT-T_cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.38e-05 | 176 | 98 | 5 | bb41e9478373726eb460af764de0277b2d09928e | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.38e-05 | 176 | 98 | 5 | dee780cfa85234a7cd7bf440b66b84cec959893e | |
| ToppCell | LPS-antiTNF-Lymphocytic_NKT-T_cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.38e-05 | 176 | 98 | 5 | ea27e18407b8a13e8212830da859efeb8f158690 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)|343B / Donor, Lineage, Cell class and subclass (all cells) | 4.38e-05 | 176 | 98 | 5 | f33ab41d121b59d871ad7d48ca021524a027d2ef | |
| ToppCell | LPS-antiTNF-Lymphocytic_NKT-T_cells-T-cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.38e-05 | 176 | 98 | 5 | bfbab3c5b738b3b0b1540f2059d0245fbd8c0031 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.50e-05 | 177 | 98 | 5 | da8802a6351d3e510822f82e2fde8a4314a2216e | |
| ToppCell | Ciliated_cells-B-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 4.50e-05 | 177 | 98 | 5 | c38138fb5ad9766c2d240811210c854338cd612e | |
| ToppCell | Ciliated_cells-A-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 4.62e-05 | 178 | 98 | 5 | 255473ee6df8a13079fb3bb61038162a40cb4c2c | |
| ToppCell | Control-Lymphocytic_NKT-T_cells-T-cells|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.62e-05 | 178 | 98 | 5 | 910f8bea19d335455aba24e6a07b4834b709db5d | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.62e-05 | 178 | 98 | 5 | de5d50d7ca9ee9eb62f50c88a0c6d47f0694b2e6 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.62e-05 | 178 | 98 | 5 | 3b12db04006db6e94fc45649a4b3a63b92f21a61 | |
| ToppCell | Control-Lymphocytic_NKT-T_cells|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.75e-05 | 179 | 98 | 5 | d892d9496f1c33e23312092591eb2e968e736f7d | |
| ToppCell | Control-Stromal-SMC|Control / Disease state, Lineage and Cell class | 4.75e-05 | 179 | 98 | 5 | 1378051bc62009eec2dbecf3d5d89baedbeb84eb | |
| ToppCell | Children_(3_yrs)-Mesenchymal-myofibroblast_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.87e-05 | 180 | 98 | 5 | 01f2e5d96016823482f89ba503d007d4bd88eeac | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.00e-05 | 181 | 98 | 5 | 6a6bd8e020cb0929b6ecdcb55d467ad24fecfaf0 | |
| ToppCell | COVID-19-Endothelial_cells-Capillary_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 5.00e-05 | 181 | 98 | 5 | c5f9c92af1384d9089c65afdf41c6feb8345a3ae | |
| ToppCell | wk_08-11-Epithelial-Proximal_epithelial-Ciliated|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 5.00e-05 | 181 | 98 | 5 | 8eed9d46d924b16f6dd1a025ff612244b02b4391 | |
| ToppCell | TCGA-Endometrium-Primary_Tumor-Endometrial_Adenocarcinoma-Endometrioid-4|TCGA-Endometrium / Sample_Type by Project: Shred V9 | 5.00e-05 | 181 | 98 | 5 | 51d91b923920463245e95d65c6a5197e21d34d73 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.00e-05 | 181 | 98 | 5 | 6956ecd6264f7469a25e555673bce4eb97d28f7a | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.00e-05 | 181 | 98 | 5 | dfce05bd472f67e6e2bb60ebd6fd34f0a9aeeca6 | |
| ToppCell | Adult-Epithelial-ciliated_cell-D122|Adult / Lineage, Cell type, age group and donor | 5.13e-05 | 182 | 98 | 5 | 7ded554a4b441e6496db673ba206c0d76ccad7d9 | |
| Disease | Depressive disorder | 2.47e-08 | 289 | 92 | 10 | C0011581 | |
| Disease | Mental Depression | 1.05e-07 | 254 | 92 | 9 | C0011570 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 8.38e-06 | 152 | 92 | 6 | DOID:0060041 (implicated_via_orthology) | |
| Disease | Autistic Disorder | 1.81e-05 | 261 | 92 | 7 | C0004352 | |
| Disease | protein C measurement | 1.93e-05 | 17 | 92 | 3 | EFO_0004633 | |
| Disease | Long Qt Syndrome 2 | 2.88e-05 | 3 | 92 | 2 | C3150943 | |
| Disease | Bronchial Diseases | 2.88e-05 | 3 | 92 | 2 | C0006261 | |
| Disease | Attention Deficit Disorder | 4.33e-05 | 22 | 92 | 3 | C0041671 | |
| Disease | Minimal Brain Dysfunction | 4.33e-05 | 22 | 92 | 3 | C1321905 | |
| Disease | Attention deficit hyperactivity disorder | 5.66e-05 | 24 | 92 | 3 | C1263846 | |
| Disease | congenital heart disease (implicated_via_orthology) | 6.55e-05 | 69 | 92 | 4 | DOID:1682 (implicated_via_orthology) | |
| Disease | attention deficit hyperactivity disorder (implicated_via_orthology) | 9.08e-05 | 28 | 92 | 3 | DOID:1094 (implicated_via_orthology) | |
| Disease | myocardial infarction | 1.15e-04 | 350 | 92 | 7 | EFO_0000612 | |
| Disease | nonsyndromic deafness (implicated_via_orthology) | 1.43e-04 | 6 | 92 | 2 | DOID:0050563 (implicated_via_orthology) | |
| Disease | Autism Spectrum Disorders | 1.48e-04 | 85 | 92 | 4 | C1510586 | |
| Disease | Unipolar Depression | 1.64e-04 | 259 | 92 | 6 | C0041696 | |
| Disease | sialic acid-binding Ig-like lectin 12 measurement | 2.66e-04 | 8 | 92 | 2 | EFO_0802066 | |
| Disease | colitis (biomarker_via_orthology) | 3.08e-04 | 42 | 92 | 3 | DOID:0060180 (biomarker_via_orthology) | |
| Disease | Colorectal Carcinoma | 3.48e-04 | 702 | 92 | 9 | C0009402 | |
| Disease | Semantic-Pragmatic Disorder | 5.19e-04 | 11 | 92 | 2 | C0454655 | |
| Disease | cocaine use | 5.19e-04 | 11 | 92 | 2 | C3496069 | |
| Disease | Auditory Processing Disorder, Central | 5.19e-04 | 11 | 92 | 2 | C0751257 | |
| Disease | Language Delay | 5.19e-04 | 11 | 92 | 2 | C0023012 | |
| Disease | Language Development Disorders | 5.19e-04 | 11 | 92 | 2 | C0023014 | |
| Disease | Speech Delay | 5.19e-04 | 11 | 92 | 2 | C0241210 | |
| Disease | platelet component distribution width | 5.87e-04 | 755 | 92 | 9 | EFO_0007984 | |
| Disease | Pathological accumulation of air in tissues | 6.22e-04 | 12 | 92 | 2 | C0013990 | |
| Disease | Bipolar Disorder | 7.42e-04 | 477 | 92 | 7 | C0005586 | |
| Disease | Seasonal Affective Disorder | 1.12e-03 | 16 | 92 | 2 | C0085159 | |
| Disease | cathepsin L1 measurement | 1.12e-03 | 16 | 92 | 2 | EFO_0010619 | |
| Disease | Grand Mal Status Epilepticus | 1.22e-03 | 67 | 92 | 3 | C0311335 | |
| Disease | Status Epilepticus, Subclinical | 1.22e-03 | 67 | 92 | 3 | C0751522 | |
| Disease | Simple Partial Status Epilepticus | 1.22e-03 | 67 | 92 | 3 | C0751524 | |
| Disease | Non-Convulsive Status Epilepticus | 1.22e-03 | 67 | 92 | 3 | C0751523 | |
| Disease | Petit mal status | 1.22e-03 | 67 | 92 | 3 | C0270823 | |
| Disease | Complex Partial Status Epilepticus | 1.22e-03 | 67 | 92 | 3 | C0393734 | |
| Disease | partial epilepsy | 1.27e-03 | 17 | 92 | 2 | EFO_0004263 | |
| Disease | Status Epilepticus | 1.27e-03 | 68 | 92 | 3 | C0038220 | |
| Disease | Nonorganic psychosis | 1.32e-03 | 69 | 92 | 3 | C0349204 | |
| Disease | Alcoholic Intoxication, Chronic | 1.54e-03 | 268 | 92 | 5 | C0001973 | |
| Disease | epilepsy (implicated_via_orthology) | 1.72e-03 | 163 | 92 | 4 | DOID:1826 (implicated_via_orthology) | |
| Disease | Schizophrenia | 1.75e-03 | 883 | 92 | 9 | C0036341 | |
| Disease | Colorectal Neoplasms | 1.78e-03 | 277 | 92 | 5 | C0009404 | |
| Disease | body weight | CACNA1C IL13RA1 DPYD NRCAM ANO5 CHD8 HHLA2 PTPN14 DNAH12 CDC16 TACR1 | 1.88e-03 | 1261 | 92 | 11 | EFO_0004338 |
| Disease | age of onset of asthma | 1.95e-03 | 79 | 92 | 3 | OBA_2001001 | |
| Disease | leptin measurement | 2.10e-03 | 81 | 92 | 3 | EFO_0005000 | |
| Disease | sex interaction measurement, bilirubin measurement | 2.13e-03 | 22 | 92 | 2 | EFO_0004570, EFO_0008343 | |
| Disease | Epilepsy, Cryptogenic | 2.17e-03 | 82 | 92 | 3 | C0086237 | |
| Disease | Awakening Epilepsy | 2.17e-03 | 82 | 92 | 3 | C0751111 | |
| Disease | Aura | 2.17e-03 | 82 | 92 | 3 | C0236018 | |
| Disease | short-term memory | 2.25e-03 | 83 | 92 | 3 | EFO_0004335 | |
| Disease | QRS duration, response to sulfonylurea | 2.33e-03 | 23 | 92 | 2 | EFO_0005055, EFO_0007922 | |
| Disease | peptic ulcer disease, Peptic ulcer and gastro-oesophageal reflux disease (GORD) drug use measurement, gastroesophageal reflux disease | 2.54e-03 | 24 | 92 | 2 | EFO_0003948, EFO_0009923, MONDO_0004247 | |
| Disease | platelet crit | 2.90e-03 | 952 | 92 | 9 | EFO_0007985 | |
| Disease | acute necrotizing pancreatitis (biomarker_via_orthology) | 2.98e-03 | 26 | 92 | 2 | DOID:0080998 (biomarker_via_orthology) | |
| Disease | atopic dermatitis (is_implicated_in) | 2.98e-03 | 26 | 92 | 2 | DOID:3310 (is_implicated_in) | |
| Disease | Hypertensive disease | 2.99e-03 | 190 | 92 | 4 | C0020538 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TYMLRTNHWKYIAYS | 416 | Q6UWY0 | |
| KYKNYSYLHCEWATI | 671 | Q9HCK8 | |
| YTLHQNWARFSYFYK | 271 | Q75V66 | |
| REHLNYWYSLKAYYL | 486 | P45844 | |
| NYKYIIQCSVLYNSW | 1251 | Q8N7X0 | |
| VTVGYHYNWDSKKYS | 171 | Q13686 | |
| QIRYFTHHSVKYFWN | 136 | Q9H7F0 | |
| EENWYNTYSSNLYKH | 141 | P31371 | |
| LYVWNNYHVVKYSLD | 376 | Q9HAR2 | |
| HYYANKYSFWLTTIP | 1666 | P08572 | |
| KYHLRFSYTRRNYMW | 151 | Q99758 | |
| WYIHKYVQSQYGASV | 501 | Q12882 | |
| YLLADNRHYTFYVWK | 346 | Q5I7T1 | |
| YQEYKEAASSYQEAW | 466 | Q9BUB4 | |
| VSNSKTRAIYYAWYE | 411 | Q8TBY9 | |
| LKSAHYIELGSYQYW | 6 | Q6TCH7 | |
| QQWIWLQTHYYITYH | 321 | Q99743 | |
| LQTHYYITYHQWNSK | 326 | Q99743 | |
| SPFYYYQVEAWKTHV | 486 | P35228 | |
| SVLWNLYHYYKQFFD | 3911 | Q9NU22 | |
| QINSHYWCNDYKSYS | 76 | O75951 | |
| YRIYYWKTQSSSKRN | 881 | Q92823 | |
| YYSHRETVNGSWYIQ | 216 | P55212 | |
| KHKIWFTIYDNQYLY | 4191 | Q5CZC0 | |
| SANYHALYRYFVELW | 216 | O95279 | |
| ISSNWVSNYEKYYLI | 696 | O00443 | |
| FHVQSWYDEVKDYTY | 126 | Q9H0B8 | |
| IHWKYQDSYKVHSYY | 61 | Q9UM44 | |
| HIYVWYCQNKPRSEY | 2016 | O60229 | |
| GARKHYETYVEKYNW | 406 | Q6ZR08 | |
| LEYNYVKQWRHSYTA | 116 | P27487 | |
| VKQWRHSYTASYDIY | 121 | P27487 | |
| TNTQSFYREKWIYVH | 76 | Q8TCJ0 | |
| YWTDLYTQRIYRANK | 2606 | P98164 | |
| KKETYQSVYNWQYVH | 396 | Q9Y3T9 | |
| TTLLWVQYYLAQHYD | 371 | Q9BXJ9 | |
| TNYTLYYWHRSLEKI | 156 | P78552 | |
| AAVHYYAIWKYLYRS | 216 | Q15546 | |
| YWTKYYTLHNAIIED | 276 | Q15646 | |
| YYYWHLRKQVLHSQC | 131 | Q96NE9 | |
| KATGVLYDYVNKYHW | 4076 | P04114 | |
| YWLAQCLYLTAQYHR | 41 | Q13042 | |
| LYHNLQEYAKRYSWS | 126 | Q6ICH7 | |
| QTWALYVANRYDYSV | 191 | Q5T8I9 | |
| NYLYNHLTYAVNIWS | 151 | P24394 | |
| DYFHVNANYIVWKTN | 56 | P40189 | |
| NQHQYKVWYVVNSTY | 1226 | Q13936 | |
| YSSQWHVVNYKYEQY | 116 | Q96BY6 | |
| KTYSTDWHVVNYKYE | 106 | Q5JSL3 | |
| TYNSDWHLVNYKYED | 116 | Q9BZ29 | |
| RWVIYNEVIQTSKYY | 651 | Q9H5Z1 | |
| RQDKWEHISYSQYYL | 126 | Q96GR2 | |
| LYTNKHTQWFYFRVQ | 296 | Q5U5Z8 | |
| YSWNISRKYCQNRYT | 51 | P16109 | |
| CQEKRNTYFAEYWYQ | 81 | Q8NDX9 | |
| AYKHLGQTSNYYWID | 601 | Q9UHC6 | |
| SAQAYHSWYSLHYKR | 271 | O60383 | |
| YTEANRYDYVHVGTW | 486 | Q13255 | |
| KLISWYDNEYGYSHR | 381 | O14556 | |
| HTNYSLKYKLRWYGQ | 166 | O75462 | |
| HYISDPTYYNSWRRQ | 2076 | Q58EX2 | |
| SSQTYQYWVHYLDHD | 916 | Q56UN5 | |
| NWYNTYSSNIYKHGD | 146 | Q9NP95 | |
| YRKHNKQWYEKSYQS | 376 | Q96NL0 | |
| SWNSYVDYKIFLHTN | 31 | Q9Y5W9 | |
| DWELSYAYYSNIATK | 626 | Q68CR1 | |
| EVSSVWFKQYIYVYH | 171 | P0C866 | |
| NSYYDWYILVTNKCH | 411 | Q8IVG5 | |
| LKHQWQQAAEYMYSY | 66 | Q15573 | |
| ENWYNTYASTLYKHS | 141 | O43320 | |
| TVVNFTYAVHNEWYY | 86 | P25103 | |
| VSWLQQEATRYQYYL | 106 | Q15678 | |
| WYVDDPYQKYHDRTN | 171 | Q9NZE8 | |
| DHYYDTSWKRLIFYI | 551 | Q9NSC7 | |
| WYYRQSEVPDSVYQH | 186 | Q9P2R6 | |
| NVYYKHRWVAEHYFL | 91 | P60153 | |
| IWYKGQIRDLYHYVT | 66 | Q13046 | |
| YYFQVERGSRKWNYI | 246 | Q96PQ1 | |
| TDVRKWVNYSAHYSY | 856 | Q8WXE9 | |
| EFDWKSYIQDSRYHY | 311 | P35498 | |
| LTEVHYWYQGKTYVY | 336 | Q9Y2M2 | |
| RSYRYKLLNWAYQQV | 186 | Q9UHE8 | |
| YLLADNRHYTFYVWK | 346 | Q5BKT4 | |
| QQWIWLQTHYYITYH | 346 | O15516 | |
| LQTHYYITYHQWNSR | 351 | O15516 | |
| WTYQVHQERLYQEYN | 96 | Q9NPC3 | |
| YRLYGQWKNETYNSH | 521 | Q8NI27 | |
| KVYYYNARTRESAWT | 146 | O14776 | |
| RYYWDEYKASNPHAS | 566 | Q5XPI4 | |
| DHDIGVYSVYWYQQR | 46 | P12018 | |
| EDKYVYIWSTYHDLS | 806 | Q5JSH3 | |
| WETFVTYYNLKTHQR | 371 | Q9P1Z0 | |
| SRYEKLQATYWYHRF | 361 | P02549 | |
| HSTISGNEYVYWYRQ | 41 | A0A087WT03 | |
| VYTNVIYYQKWINAT | 251 | Q7RTY5 | |
| WYYYLTHRRKEQTLF | 126 | Q8IYP9 | |
| KRDAFVYAIKNHYWY | 116 | Q9HD45 | |
| DNKRYRYAYHRSSWL | 156 | Q9UMR3 | |
| RKDSRTVYQYQYTNW | 1111 | P08575 | |
| VYTQVTYYRNWIASK | 401 | Q6ZMR5 | |
| EYRSENISWDYIHYT | 476 | Q6PIF6 |